The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients

INTRODUCTION: The effect of hemogram parameters on survival has been evaluated in many studies for patients who have urogenital tumor. In this study, we aimed to evaluate the neutrophil-lymphocyte ratio (NLR) on disease specific survival (DSS) in patients who have testicular tumor. METHODS: The dat...

Full description

Bibliographic Details
Main Authors: Nurullah Hamidi, Evren Süer, Mehmet İlker Gökçe, Yaşar Bedük
Format: Article
Language:English
Published: Van Yuzuncu Yil University, School of Medicine 2017-05-01
Series:Van Tıp Dergisi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-75537
_version_ 1797421103350546432
author Nurullah Hamidi
Evren Süer
Mehmet İlker Gökçe
Yaşar Bedük
author_facet Nurullah Hamidi
Evren Süer
Mehmet İlker Gökçe
Yaşar Bedük
author_sort Nurullah Hamidi
collection DOAJ
description INTRODUCTION: The effect of hemogram parameters on survival has been evaluated in many studies for patients who have urogenital tumor. In this study, we aimed to evaluate the neutrophil-lymphocyte ratio (NLR) on disease specific survival (DSS) in patients who have testicular tumor. METHODS: The data of 67 patients who treated for primary testicular tumor at our clinic between January 2000 and December 2010 was evaluated retrospectively. Patients' age, histological type of tumor, pathologic stage, serum neutrophil and serum lymphocyte counts and NLR values were recorded. RESULTS: For all patients, mean age, mean serum neutrophil, lymphocyte counts and mean NLR were 33+-8, 4800+-2100, 1100+-520 and 3,69+-1.1, respectively. In histopathological examination, pure seminoma, pure non-seminom and mix histologic type were detected in 21(31.4%), 23(34.3%) and 23(34.3%) patients, respectively. Stage 1 disease and stage ≥2 disease were revealed in 42(62%) and 25(38%)of the patients. During median 67 months follow-up period, DSS rate was 91%. According to previous studies, we determined NLR cut-off value as 4. Patients were divided into two groups as NLR≤4 and NLR>4. There was no statistically significant difference on DSS between two groups. DISCUSSION AND CONCLUSION: According to our outcomes, we observed that NLR was not a prognostic factor to predict of DSS. However, high patient volume and prospective trials are needed to support our results.
first_indexed 2024-03-09T07:12:06Z
format Article
id doaj.art-290b010ad1e84c86856d6ea49bec5430
institution Directory Open Access Journal
issn 2587-0351
language English
last_indexed 2024-03-09T07:12:06Z
publishDate 2017-05-01
publisher Van Yuzuncu Yil University, School of Medicine
record_format Article
series Van Tıp Dergisi
spelling doaj.art-290b010ad1e84c86856d6ea49bec54302023-12-03T09:01:10ZengVan Yuzuncu Yil University, School of MedicineVan Tıp Dergisi2587-03512017-05-0124210610910.5505/vtd.2017.75537VTD-75537The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor PatientsNurullah Hamidi0Evren Süer1Mehmet İlker Gökçe2Yaşar Bedük3Department of Urology, Ankara University, Ankara, TurkeyDepartment of Urology, Ankara University, Ankara, TurkeyDepartment of Urology, Ankara University, Ankara, TurkeyDepartment of Urology, Ankara University, Ankara, TurkeyINTRODUCTION: The effect of hemogram parameters on survival has been evaluated in many studies for patients who have urogenital tumor. In this study, we aimed to evaluate the neutrophil-lymphocyte ratio (NLR) on disease specific survival (DSS) in patients who have testicular tumor. METHODS: The data of 67 patients who treated for primary testicular tumor at our clinic between January 2000 and December 2010 was evaluated retrospectively. Patients' age, histological type of tumor, pathologic stage, serum neutrophil and serum lymphocyte counts and NLR values were recorded. RESULTS: For all patients, mean age, mean serum neutrophil, lymphocyte counts and mean NLR were 33+-8, 4800+-2100, 1100+-520 and 3,69+-1.1, respectively. In histopathological examination, pure seminoma, pure non-seminom and mix histologic type were detected in 21(31.4%), 23(34.3%) and 23(34.3%) patients, respectively. Stage 1 disease and stage ≥2 disease were revealed in 42(62%) and 25(38%)of the patients. During median 67 months follow-up period, DSS rate was 91%. According to previous studies, we determined NLR cut-off value as 4. Patients were divided into two groups as NLR≤4 and NLR>4. There was no statistically significant difference on DSS between two groups. DISCUSSION AND CONCLUSION: According to our outcomes, we observed that NLR was not a prognostic factor to predict of DSS. However, high patient volume and prospective trials are needed to support our results.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-75537neutrophil-lymphocyte ratiosurvivaltesticular tumor
spellingShingle Nurullah Hamidi
Evren Süer
Mehmet İlker Gökçe
Yaşar Bedük
The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients
Van Tıp Dergisi
neutrophil-lymphocyte ratio
survival
testicular tumor
title The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients
title_full The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients
title_fullStr The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients
title_full_unstemmed The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients
title_short The Effect of Preoperative Neutrophil-Lymphocyte Ratio on Disease Specific Survival in Testicular Tumor Patients
title_sort effect of preoperative neutrophil lymphocyte ratio on disease specific survival in testicular tumor patients
topic neutrophil-lymphocyte ratio
survival
testicular tumor
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-75537
work_keys_str_mv AT nurullahhamidi theeffectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT evrensuer theeffectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT mehmetilkergokce theeffectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT yasarbeduk theeffectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT nurullahhamidi effectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT evrensuer effectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT mehmetilkergokce effectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients
AT yasarbeduk effectofpreoperativeneutrophillymphocyteratioondiseasespecificsurvivalintesticulartumorpatients